Literature DB >> 17257616

Dimer dissociation and unfolding mechanism of coagulation factor XI apple 4 domain: spectroscopic and mutational analysis.

Paul W Riley1, Hong Cheng, Dharmaraj Samuel, Heinrich Roder, Peter N Walsh.   

Abstract

The blood coagulation protein factor XI (FXI) consists of a pair of disulfide-linked chains each containing four apple domains and a catalytic domain. The apple 4 domain (A4; F272-E362) mediates non-covalent homodimer formation even when the cysteine involved in an intersubunit disulfide is mutated to serine (C321S). To understand the role of non-covalent interactions stabilizing the FXI dimer, equilibrium unfolding of wild-type A4 and its C321S variant was monitored by circular dichroism, intrinsic tyrosine fluorescence and dynamic light scattering measurements as a function of guanidine hydrochloride concentration. Global analysis of the unimolecular unfolding transition of wild-type A4 revealed a partially unfolded equilibrium intermediate at low to moderate denaturant concentrations. The optically detected equilibrium of C321S A4 also fits best to a three-state model in which the native dimer unfolds via a monomeric intermediate state. Dimer dissociation is characterized by a dissociation constant, K(d), of approximately 90 nM (in terms of monomer), which is in agreement with the dissociation constant measured independently using fluorescence anisotropy. The results imply that FXI folding occurs via a monomeric equilibrium intermediate. This observation sheds light on the effect of certain naturally occurring mutations, such as F283L, which lead to intracellular accumulation of non-native forms of FXI. To investigate the structural and energetic consequences of the F283L mutation, which perturbs a cluster of aromatic side-chains within the core of the A4 monomer, it was introduced into the dissociable dimer, C321S A4. NMR chemical shift analysis confirmed that the mutant can assume a native-like dimeric structure. However, equilibrium unfolding measurements show that the mutation causes a fourfold increase in the K(d) value for dissociation of the native dimer and a 1 kcal/mol stabilization of the monomer, resulting in a highly populated intermediate. Since the F283 side-chain does not directly participate in the dimer interface, we propose that the F283L mutation leads to increased dimer dissociation by stabilizing a monomeric state with altered side-chain packing that is unfavorable for homodimer formation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17257616      PMCID: PMC1945241          DOI: 10.1016/j.jmb.2006.12.066

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  31 in total

1.  Quantification of protein-protein interactions using fluorescence polarization.

Authors:  D M Jameson; S E Seifried
Journal:  Methods       Date:  1999-10       Impact factor: 3.608

2.  Noncovalent interactions of the Apple 4 domain that mediate coagulation factor XI homodimerization.

Authors:  R Dorfman; P N Walsh
Journal:  J Biol Chem       Date:  2000-11-22       Impact factor: 5.157

3.  Crystal structure of the factor XI zymogen reveals a pathway for transactivation.

Authors:  Evangelos Papagrigoriou; Paul A McEwan; Peter N Walsh; Jonas Emsley
Journal:  Nat Struct Mol Biol       Date:  2006-05-14       Impact factor: 15.369

4.  A quantitative model for allosteric control of purine reduction by murine ribonucleotide reductase.

Authors:  C P Scott; O B Kashlan; J D Lear; B S Cooperman
Journal:  Biochemistry       Date:  2001-02-13       Impact factor: 3.162

5.  Factor IX activation by factor XIa proceeds without release of a free intermediate.

Authors:  A S Wolberg; D P Morris; D W Stafford
Journal:  Biochemistry       Date:  1997-04-08       Impact factor: 3.162

6.  A classification system for cross-reactive material-negative factor XI deficiency.

Authors:  Dmitri V Kravtsov; Paul E Monahan; David Gailani
Journal:  Blood       Date:  2005-02-22       Impact factor: 22.113

7.  Factor XI deficiency database: an interactive web database of mutations, phenotypes, and structural analysis tools.

Authors:  Rebecca E Saunders; Niamh M O'Connell; Christine A Lee; David J Perry; Stephen J Perkins
Journal:  Hum Mutat       Date:  2005-09       Impact factor: 4.878

8.  Factor XIa dimer in the activation of factor IX.

Authors:  Dipali Sinha; Mariola Marcinkiewicz; James D Lear; Peter N Walsh
Journal:  Biochemistry       Date:  2005-08-02       Impact factor: 3.162

9.  Novel missense mutations in two patients with factor XI deficiency (Val271Leu and Tyr351Ser) and one patient with combined factor XI and factor IX deficiency (Phe349Val).

Authors:  G Jayandharan; R V Shaji; S C Nair; M Chandy; A Srivastava
Journal:  J Thromb Haemost       Date:  2005-04       Impact factor: 5.824

10.  Structural characterization of an equilibrium unfolding intermediate in cytochrome c.

Authors:  Ramil F Latypov; Hong Cheng; Navid A Roder; Jiaru Zhang; Heinrich Roder
Journal:  J Mol Biol       Date:  2006-02-03       Impact factor: 5.469

View more
  9 in total

1.  Destabilization of the dimer interface is a common consequence of diverse ALS-associated mutations in metal free SOD1.

Authors:  Helen R Broom; Jessica A O Rumfeldt; Kenrick A Vassall; Elizabeth M Meiering
Journal:  Protein Sci       Date:  2015-10-05       Impact factor: 6.725

2.  Solution structure of the A4 domain of factor XI sheds light on the mechanism of zymogen activation.

Authors:  Dharmaraj Samuel; Hong Cheng; Paul W Riley; Adrian A Canutescu; Chandrasekaran Nagaswami; John W Weisel; Zimei Bu; Peter N Walsh; Heinrich Roder
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-20       Impact factor: 11.205

3.  Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa.

Authors:  Wenman Wu; Dipali Sinha; Sergei Shikov; Calvin K Yip; Thomas Walz; Paul C Billings; James D Lear; Peter N Walsh
Journal:  J Biol Chem       Date:  2008-04-25       Impact factor: 5.157

4.  LcrH, a class II chaperone from the type three secretion system, has a highly flexible native structure.

Authors:  Sunny K Singh; Aimee L Boyle; Ewan R G Main
Journal:  J Biol Chem       Date:  2012-12-11       Impact factor: 5.157

5.  The H2A-H2B dimeric kinetic intermediate is stabilized by widespread hydrophobic burial with few fully native interactions.

Authors:  Paul J Guyett; Lisa M Gloss
Journal:  J Mol Biol       Date:  2011-11-23       Impact factor: 5.469

Review 6.  Structure and function of factor XI.

Authors:  Jonas Emsley; Paul A McEwan; David Gailani
Journal:  Blood       Date:  2010-01-28       Impact factor: 22.113

7.  A catalytic domain exosite (Cys527-Cys542) in factor XIa mediates binding to a site on activated platelets.

Authors:  Tara N Miller; Dipali Sinha; T Regan Baird; Peter N Walsh
Journal:  Biochemistry       Date:  2007-11-17       Impact factor: 3.162

Review 8.  An update on factor XI structure and function.

Authors:  Bassem M Mohammed; Anton Matafonov; Ivan Ivanov; Mao-Fu Sun; Qiufang Cheng; S Kent Dickeson; Chan Li; David Sun; Ingrid M Verhamme; Jonas Emsley; David Gailani
Journal:  Thromb Res       Date:  2017-10-10       Impact factor: 3.944

9.  Chemical and thermal unfolding of a global staphylococcal virulence regulator with a flexible C-terminal end.

Authors:  Avisek Mahapa; Sukhendu Mandal; Anindya Biswas; Biswanath Jana; Soumitra Polley; Subrata Sau; Keya Sau
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.